Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.40
2.27%
After-hours: Aug 15, 2025, 04:10 PM EDT

Serina Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.21M 5.27M -2.68M -1.26M
Depreciation & Amortization
194K 90K 61.27K 33.37K
Stock-Based Compensation
2.6M 25K 7.11K 82.94K
Other Working Capital
-1.72M -312K 153.5K -1.61M
Other Non-Cash Items
-5.4M -7.94M 148.25K -122.21K
Deferred Income Tax
n/a n/a 401.79K -225.38K
Change in Working Capital
-3.32M 81K -11.94K -754.79K
Operating Cash Flow
-17.14M -2.48M -2.08M -2.25M
Capital Expenditures
-22K -504K -9.68K -108.43K
Cash Acquisitions
n/a n/a n/a 466K
Purchase of Investments
n/a n/a n/a -666K
Sales Maturities Of Investments
n/a n/a 990.62K 931.75K
Other Investing Acitivies
n/a n/a n/a 200K
Investing Cash Flow
-22K -504K 980.94K 823.32K
Debt Repayment
2.88M 10.05M 1.31M -12.91K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.34M n/a n/a 1M
Financial Cash Flow
13.21M 10.07M 1.31M 1.08M
Net Cash Flow
-3.95M 7.09M 217.38K -350.21K
Free Cash Flow
-17.16M -2.98M -2.09M -2.36M